Sino Health Summit Drives New Transformation in Pharmaceutical Industry: BeiYang Advances Sector Progress Through Efficiency Upgrades

On September 24, the 2021 Westpu Conference opened in Boao, Hainan. As an annual grand event for the pharmaceutical industry, this year’s Westpu Conference, themed “Efficiency Revolution – Building a Sufficient and Balanced New Health Industry,” gathered industry leaders to analyze development trends in the new health industry ecosystem and jointly explore efficiency upgrades. Baheal Medical once again joined hands with numerous leading health enterprises at the Westpu Conference, bringing forth new ideas on “efficiency upgrades” to accelerate the development of the new health industry.

As numerous landmark healthcare policies are gradually implemented, the health industry has entered a “deep-water” phase, making it an inevitable trend to shape a more standardized and efficient industry ecosystem. At the opening ceremony of the Xipu Conference on September 24, Fu Gang, Chairman of Baheal Medical Group, delivered a keynote address themed “Driving Industry Progress Through Efficiency Upgrades,” offering new insights for the industry’s exploration of an efficiency revolution.

Opening Remarks by Fu Gang, Chairman of Baheal Medical Group

“To drive industry progress, we must first identify the primary contradictions within the sector. Amidst the continuous evolution and refinement of regulations, the principal contradiction in China’s pharmaceutical industry lies between standardized, efficient advanced models and outdated ones,” pointed out Fu Gang. He noted that while policy changes pose challenges to China’s pharmaceutical industry, they also bring three major opportunities: a shift from treatment-focused care to prevention, the migration of prescription drugs to out-of-hospital channels, and accelerated approval processes for innovative drugs.

Against this backdrop, how can pharmaceutical companies seize opportunities to improve quality and efficiency? Fu Gang believes that aligning with macro trends is a prerequisite for enhancing corporate efficiency. “The underlying logic of efficiency upgrading lies in the strategic optimization of resource allocation within the policy framework, specifically by implementing three key pathways: ‘leveraging digital marketing to avoid structural waste,’ ‘allocating resources rationally across the product lifecycle,’ and ‘enhancing collaborative efficiency through professional platforms.’”

Adhering to this “methodology,” Baheal Medical Co., Ltd. (hereinafter referred to as “Baheal Medical”), a subsidiary of Baheal Pharmaceutical Group, has achieved substantial progress in practical implementation. Baheal Medical’s comprehensive data platform generates a precision-guided market map, enabling accurate identification of target terminals for various products. Furthermore, since its inception, Baheal Medical has emphasized the “dual-track parallel” approach of brand activities and channel activities, effectively allocating resources according to different stages of the brand lifecycle. Additionally, leveraging the core advantages of its commercialization platform, Baheal Medical has fostered the coordinated development of multiple brand tracks, gradually establishing three high-quality brand matrices driving diversified growth: “OTC and General Health Products,” “OTX and Other Prescription Drugs,” and “Oncology and Other Critical Care Medicines.”

“Baheal Patient Service Center” Launches

As the health industry structure evolves, it is not only essential to ensure access to high-quality products but, more importantly, to provide consumers with professional and comprehensive health services. To this end, Baheal Medical has joined forces with leading experts in obstetrics and gynecology, gastroenterology, hepatology, and ophthalmology, as well as top-100 pharmacy chains, to jointly launch the “Baheal Patient Service Center,” safeguarding patients’ health management. Furthermore, amid the trend of consumption upgrading, Baheal’s Mengtuo Yaozhuang brand has collaborated with two major chains, Yixintang and Yikang, to initiate the “Mengtuo Yaozhuang Hundred Model Stores” project, offering consumers additional value-added services.

“Mengtuo Yaozhuang 100 Model Stores” Launch

“Collaboration, Innovation, Technology, R&D, and Capital” are the core hallmarks of the Westpharm Conference, which aligns perfectly with Baheal Medical’s development philosophy. Fu Gang believes that industry progress is the result of combined efforts from multiple stakeholders, requiring regulation and synergy as a solid foundation, and even more so, technology and innovation to lead the way.

“Baheal brings standardized and efficient solutions to the industry, and is further committed to expanding the boundaries of the health industry through cross-sector integration. Leveraging the accumulated resources of Baheal Medical’s brand commercialization platform, Baheal is relentlessly promoting the integration of the health industry with multiple sectors such as finance and real estate.”

At the level of innovation incubation, Baheal Medical’s strategic layout driven by technological innovation is gradually becoming a reality: Baheal Medical’s brand commercialization platform provides an “expressway” for the market entry of innovative brands. Leveraging the abundant resources accumulated over years through its commercialization platform and its relentless pursuit of innovation, Baheal Investment, a subsidiary of Baheal Medical, operates as an “industry investor,” offering dual support of “financial incubation + industrial incubation” to innovative enterprises. By promoting ecological resource synergy through industrial investment, it helps companies achieve rapid growth and identify the “shortest path” to value realization. This year, three innovative healthcare companies incubated by Baheal Investment were listed in the 5th edition of the “Top 100 Future Healthcare Companies,” demonstrating its strength.

As a typical case of industrial real estate, Baheal Medical launched its first Health City Complex project in Qingdao. By integrating industry, innovation, and living, the project aggregates health industries, innovative enterprises, and healthy communities, providing spatial support for innovative companies and building a talent base for the health industry, thereby helping the health industry achieve a “multiplier effect.”

Victory belongs to those who share the same vision; prosperity comes to those who stand together through challenges. Amidst the profound transformations reshaping the pharmaceutical industry today, Baheal Medical Group consistently aligns with industry policies and opportunities, collaborating with stakeholders to actively embrace the advent of the new era in health industries. Enhancing efficiency is an inevitable path for industrial development. In the future, “Baheal” will represent not merely a single enterprise, but an innovative ecosystem within the industry, leveraging its standardized, high-efficiency growth and forward-looking strategic layout to facilitate the iterative upgrading of sector-wide development.

Conference Venue